Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07474467
PHASE1/PHASE2
Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars
Sponsor: CellinCells
View on ClinicalTrials.gov
Summary
The purpose of this clinical trial was to evaluate the safety and efficacy of a single administration of TRTP-101 in adults with atrophic scars.
Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Split-Face, Phase 1/2 Study to Evaluate the Safety and Efficacy of a Single Administration of TRTP-101 in Adults With Atrophic Scars
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
31
Start Date
2026-08-01
Completion Date
2029-08-01
Last Updated
2026-03-16
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
TRTP-101
Intradermal injection
BIOLOGICAL
Placebo
Intradermal injection
Locations (1)
Samsung Medical Center
Seoul, South Korea